Interaction between the regulatory domain of cardiac troponin C and the acidosis-resistant cardiac troponin i A162H

Cardiovascular Research

Volumn 97, Issue 3, 2013, Pages 481-489

  Pineda Sanabria, Sandra E ^a   Robertson, Ian M ^a,b   Li, Monica X ^a   Sykes, Brian D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Acidosis; Electrostatics; Myocardial ischaemia; Nuclear magnetic resonance; Troponin

Indexed keywords

ACID; ASPARTIC ACID; CALCIUM ION; GLUTAMIC ACID; HYDROGEN; TROPONIN C; TROPONIN I;

ACIDOSIS; ARTICLE; ATOM; CARBON NUCLEAR MAGNETIC RESONANCE; CONFORMATION; CONTROLLED STUDY; HEART MUSCLE; NITROGEN NUCLEAR MAGNETIC RESONANCE; PH; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STATIC ELECTRICITY; WILD TYPE;

ACIDOSIS; AMINO ACID SEQUENCE; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PROTEIN INTERACTION DOMAINS AND MOTIFS; TROPONIN C; TROPONIN I;

EID: 84874234485     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs348     Document Type: Article

References (40)

1. World Health Organization, Geneva. Causes of death. World Health Organization, Geneva; 2008. http://www.who.int/healthinfo/global-burden-disease/ cod-2008-sources-methods.pdf; 2008 (13 December 2012).
2. Lee JA, Allen DG. Mechanisms of acute ischemic contractile failure of the heart. Role of intracellular calcium. J Clin Invest 1991;88:361-367.
3. Metzger JM, Westfall MV. Covalent and noncovalent modification of thin filament action. Cardiovasc Res 2004;94:146-158.
4. Li G, Martin AF, Solaro JR. Localization of regions of troponin I important in deactivation of cardiac myofilaments by acidic pH. J Mol Cell Cardiol 2001;33:1309-1320.
5. Westfall MV, Metzger JM. Troponin I isoforms and chimeras: tuning the molecular switch of cardiac contraction. Physiology 2001;16:278-281.
6. Wolska BM, Vijayan K, Arteaga GM, Konhilas JP, Phillips RM, Kim R et al. Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions. J Physiol 2001;536:863-870.
7. Li M, Wang X, Sykes B. Structural based insights into the role of troponin in cardiac muscle pathophysiology. J Muscle Res Cell Motil 2004;25:559-579.
8. Kobayashi T, Jin L, de Tombe P. Cardiac thin filament regulation. Eur J Physiol 2008; 457:37-46.
9. Dargis R, Pearlstone JR, Barrette-Ng I, Edwards H, Smillie LB. Single mutation (A162H) in human cardiac troponin I corrects acid pH sensitivity of Ca2+-regulated actomyosin S1 ATPase. J Biol Chem 2002;277:34662-34665.
10. Day SM, Westfall MV, Fomicheva EV, Hoyer K, Yasuda S, Cross NCL et al. Histidine button engineered into cardiac troponin I protects the ischemic and failing heart. Nat Med 2006;12:181-189.
11. Day S, Westfall M, Metzger J. Tuning cardiac performance in ischemic heart disease and failure by modulating myofilament function. J Mol Med 2007;85:911-921.
12. Robertson IM, Holmes PC, Li MX, Pineda-Sanabria SE, Baryshnikova OK, Sykes BD. Elucidation of isoform-dependent pH sensitivity of troponin I by NMR spectroscopy. J Biol Chem 2012;287:4996-5007.
13. Palpant NJ, Houang EM, Delport W, Hastings KEM, Onufriev AV, Sham YY et al. Pathogenic peptide deviations support a model of adaptive evolution of chordate cardiac performance by troponin mutations. Physiol Genomics 2010;42:287-299.
14. Li M, Saude E, Wang X, Pearlstone J, Smillie L, Sykes B. Kinetic studies of calcium and cardiac troponin I peptide binding to human cardiac troponin C using NMR spectroscopy. Eur Biophys J 2002;31:245-256.
15. Robertson IM, Sun Y, Li MX, Sykes BD. A structural and functional perspective into the mechanism of Ca2+-sensitizers that target the cardiac troponin complex. J Mol Cell Cardiol 2010;49:1031-1041.
16. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 1995;6: 277-293.
17. Johnson BA, Blevins RA. NMR view: a computer program for the visualization and analysis of NMR data. J Biomol NMR 1994;4:603-614.
18. Hoffman RMB, Li MX, Sykes BD. The binding of W7, an inhibitor of striated muscle contraction, to cardiac troponin C. Biochemistry 2005;44:15750-15759.
19. Baryshnikova O, Williams T, Sykes B. Internal pH indicators for biomolecular NMR. J Biomol NMR 2008;41:5-7.
20. Baryshnikova OK. Cardiomyopathy mutations in cardiac troponin C: functional and structural consequences. Thesis. University of Alberta, Edmonton, Alberta 2008.
21. Yamazaki T, Yoshida M, Nagayama K. Complete assignments of magnetic resonances of ribonuclease H from Escherichia coli by double-and triple-resonance 2D and 3D NMR spectroscopies. Biochemistry 1993;32:5656-5669.
22. Li MX, Spyracopoulos L, Sykes BD. Binding of cardiac troponin-I147-163 induces a structural opening in human cardiac troponin-C. Biochemistry 1999;38:8289-8298.
23. Robertson IM, Baryshnikova OK, Li MX, Sykes BD. Defining the binding site of levosimendan and its analogues in a regulatory cardiac troponin C-troponin I complex. Biochemistry 2008;47:7485-7495.
24. Robertson IM, Boyko R, Sykes BD. Visualizing the principal component of 1H, 15N-HSQC NMR spectral changes that reflect protein structural or functional properties: application to troponin C. J Biomol NMR 2011;51:115-122.
25. Bundi A, Wüthrich K. Use of amide 1H-NMR titration shifts for studies of polypeptide conformation. Biopolymers 1979;18:299-311.
26. Mayer R, Lancelot G, Spach G. Side chain-backbone hydrogen bonds in peptides containing glutamic acid residues. Biopolymers 1979;18:1293-1296.
27. Forsyth WR, Antosiewicz JM, Robertson AD. Empirical relationships between protein structure and carboxyl pKa values in proteins. Proteins 2002;48:388-403.
28. Wüthrich K. NMR of Proteins and Nucleic Acids. Wiley Interscience, New York 1986.
29. Takeda S, Yamashita A, Maeda K, Maeda Y. Structure of the core domain of human cardiac troponin in the Ca2+-saturated form. Nature 2003;424:35-41.
30. Lassalle MW. Defective dynamic properties of human cardiac troponin mutations. Biosci Biotechnol Biochem 2010;74:82-91.
31. Vinogradova MV, Stone DB, Malanina GG, Karatzaferi C, Cooke R, Mendelson RA et al. Ca2+-regulated structural changes in troponin. Proc Natl Acad Sci USA 2005; 102:5038-5043.
32. Blumenschein TMA, Stone DB, Fletterick RJ, Mendelson RA, Sykes BD. Dynamics of the C-terminal region of TnI in the troponin complex in solution. Biophys J 2006;90: 2436-2444.
33. McKay RT, Tripet BP, Pearlstone JR, Smillie LB, Sykes BD. Defining the region of troponin-I that binds to troponin-C. Biochemistry 1999;38:5478-5489.
34. Li S, Hong M. Protonation, tautomerization, and rotameric structure of histidine: a comprehensive study by magic-angle-spinning solid-state NMR. J Am Chem Soc 2011;133:1534-1544.
35. Westfall MV, Metzger JM. Single amino acid substitutions define isoform-specific effects of troponin I on myofilament Ca2+ and pH sensitivity. J Mol Cell Cardiol 2007;43:107-118.
36. Liou YM, Chang JCH. Differential pH effect on calcium-induced conformational changes of cardiac troponin C complexed with cardiac and fast skeletal isoforms of troponin I and troponin T. J Biochem 2004;136:683-692.
37. Kuwahara K, Nishikimi T, Nakao K. Transcriptional regulation of the fetal cardiac gene program. J Pharmacol Sci 2012;119:198-203.
38. Huang X, Lee KJ, Beth R, Zhang C, Lemanski LF, Walker JW. Thyroid hormone regulates slow skeletal troponin I gene inactivation in cardiac troponin I null mouse hearts. J Mol Cell Cardiol 2000;32:2221-2228.
39. Cumming DVE, Seymour AML, Rix LK, Kellett R, Dhoo GK, Yacoub MH et al. Troponin I and T protein expression in experimental cardiac hypertrophy. Cardioscience 1995;6:65-70.
40. Sasse S, Brand NJ, Kyprianou P, Dhoot GK, Wade R, Arai M et al. Troponin I gene expression during human cardiac development and in end-stage heart failure. Circ Res 1993;72:932-938.